Indonesia — Fishery/Seafood Products

← back to leaderboard

Indonesia received 467 FDA import refusals in Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 308 in 2025-Q3, with the trend falling sharply year-on-year. The most-cited issues are filthy, histamine, and salmonella. No trade baseline is published for this commodity from Indonesia, so no per-$1B rate is shown here.

Of these, 436 were hazard refusals and 31 were paperwork refusals.

Exporting from Indonesia? Get an email when shipments from Indonesia are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

2 2023-Q4 2023-Q4: 2 2 2024-Q1 2024-Q1: 2 12 2024-Q2 2024-Q2: 12 24 2024-Q3 2024-Q3: 24 15 2024-Q4 2024-Q4: 15 32 2025-Q1 2025-Q1: 32 14 2025-Q2 2025-Q2: 14 308 2025-Q3 2025-Q3: 308 31 2025-Q4 2025-Q4: 31 13 2026-Q1 2026-Q1: 13 7 2026-Q2 2026-Q2: 7 7 2026-Q3 2026-Q3: 7

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Shrimp-Prawn 399 mfr inj
Tuna 37 salmonella
Fish-Other 31 filthy
Squid-Octopus 0

Recent rejections